Patents by Inventor Tomoyoshi Nozaki

Tomoyoshi Nozaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7868206
    Abstract: A compound represented by the formula (I) is used as an active ingredient in a medicament for treatment or prevention of infectious diseases caused by protozoa or bacterium. X represents halogen, Z represents —(CH2)m— wherein m is an integer of 1-5, and R represents one of the following (i)-(v): (i) hydrogen n represents an integer of 0-5, R1's independently represent hydrogen, halogen, alkoxy having 1-5 carbon atoms or alkyl having 1-5 carbon atoms. R2's independently represent hydrogen, halogen, alkoxy having 1-5 carbon atoms or alkyl having 1-5 carbon atoms. (iv) alkyl having 1-5 carbon atoms, (v) hydroxyalkyl having 1-5 carbon atoms.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: January 11, 2011
    Assignees: National University Corporation, Gunma University, National University Corporation, Nagoya Institute of Technology, Arigen Pharmaceuticals, Inc.
    Inventors: Tomoyoshi Nozaki, Takeshi Toru, Norio Shibata, Masaichi Yamamoto
  • Publication number: 20100076224
    Abstract: A compound represented by the formula (I) is used as an active ingredient in a medicament for treatment or prevention of infectious diseases caused by protozoa or bacterium. X represents halogen, Z represents —(CH2)m— wherein m is an integer of 1-5, and R represents one of the following (i)-(v): (i) hydrogen n represents an integer of 0-5, R1's independently represent hydrogen, halogen, alkoxy having 1-5 carbon atoms or alkyl having 1-5 carbon atoms. R2's independently represent hydrogen, halogen, alkoxy having 1-5 carbon atoms or alkyl having 1-5 carbon atoms. (iv) alkyl having 1-5 carbon atoms, (v) hydroxyalkyl having 1-5 carbon atoms.
    Type: Application
    Filed: December 27, 2006
    Publication date: March 25, 2010
    Applicants: National University Corporation Gunma University, National University Corporation Nagoya Institute of Technology, Arigen Pharmaceuticals ,Inc.
    Inventors: Tomoyoshi Nozaki, Takeshi Toru, Norio Shibata, Masaichi Yamamoto
  • Publication number: 20060275329
    Abstract: It is intended to provide a method of diagnosing infection with Chagas disease by screening a trypanocidal drugs for Trypanosoma cruzi which is the pathogen of Chagas disease. Using a flavin protein TcOYE specific to Trypanosoma cruzi, a trypanocidal drugs effective against Trypanosoma cruzi is screened. Using the gene sequence of TcOYE and an antibody therefor, infection with Trypanosoma cruzi is diagnosed.
    Type: Application
    Filed: October 10, 2003
    Publication date: December 7, 2006
    Applicants: Osaka Bioscience Institute, JAPAN AS REPRESENTED BY THE DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASE
    Inventors: Yoshihiro Urade, Bruno Kubata, Pius Kabututu, Tomoyoshi Nozaki